Lehr Donald P.

Avg. Two Year Performance

35% Avg. Purchase Return
16% Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return37%19%9%90%35%
Purchase Success Rate2 of 21 of 21 of 21 of 21 of 2
Average Sale Return(9%)0%0%0%0%
Sale Success Rate0 of 10 of 10 of 10 of 10 of 1
Drugs » Biotechnology

Chief Legal Officer:

Holdings: 231.56K shares


Insider Trading Sentiment: Reduce

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount